Intravenous Drug Usage
17
1
4
9
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
5.9%
1 terminated out of 17 trials
90.0%
+3.5% vs benchmark
24%
4 trials in Phase 3/4
33%
3 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (17)
Kentucky Outreach Service Kiosk (KyOSK): Reducing HIV, HCV, and Overdose Risk
Building on Needle Exchange to Optimize Prevention & Treatment
Syringe Service Based Telemedicine and Social Network Driven HIV Prevention Service Implementation
Integrated HIV Prevention and HCV Care for PWID
JING SI HERBAL TEA and Urinary Tract Symptoms in Bladder Cancer
Peripherally Inserted Internal Jugular Catheters: an Observational Study
Open Trial of a Behavioral Activation Telepsychology Intervention for People Who Inject Drugs
Low-dose Intravenous Dexamethasone at Different Times as Adjunvants for Brachial Plexus Blocks
Postoperative Analgesic Effects of Ibuprofen Versus Ketorolac in Patients Undergoing in Orthopedic Surgery
Evaluation of the Bioavailability of Dexamethasone in Healthy Subjects
Enhancing Access to Care for Chronic Hepatitis C Infected Populations in Hong Kong
Intravenous Triple Therapy in the Treatment of Helicobacter Pylori Infection and Related Complications Caused by Active Peptic Ulcer Disease
Median Effective Dose of Dexmedetomidine in Elective Upper Limb Lidocaine Intravenous Regional Anesthesia
Effect of Dexamethasone Implant on Optic Disc
Intravenous Iron for Correction of Anaemia After Colorectal Surgery
Correlates and Consequences of Increased Immune Activation in Injection Drug Users
Impact of Priming the Infusion System on the Performance of Target-controlled Infusion of Remifentanil